Bladder Cancer
The Prognostic Value of Tumor Infiltrating Lymphocytes After Radical Cystectomy for Bladder Cancer: A Systematic Review and Meta-Analysis.
February 12, 2024
Pathology focused review of morphologic subtypes and molecular variants of urothelial carcinoma with an emphasis on clinical/treatment relevance.
February 12, 2024
Successful bladder-sparing partial cystectomy for muscle-invasive domal urothelial carcinoma with sarcomatoid differentiation: a case report.
February 8, 2024
Association of Age with Non-muscle-invasive Bladder Cancer: Unearthing a Biological Basis for Epidemiological Disparities?
February 7, 2024
Achieving Benchmarks for National Quality Indicators Reduces Recurrence and Progression in Non-muscle-invasive Bladder Cancer.
February 7, 2024
HPV and Squamous Cell Carcinoma of the Bladder - Expert Commentary
February 6, 2024
Comprehensive multiplexed autoantibody profiling of patients with advanced urothelial cancer.
February 5, 2024
Standardization of the evaluation and surveillance of patients with BCG unresponsive high grade non-muscle invasive bladder cancer clinical trials.
February 5, 2024
Management of patients with muscle-invasive bladder cancer with clinical evidence of pelvic lymph node metastases.
February 2, 2024
Microbiome Profiling in Bladder Cancer Patients Using the First-morning Urine Sample.
February 2, 2024
New Photocure White Paper addressing Inequality in Bladder Cancer Care and the importance of Real World Evidence
February 1, 2024
Perioperative and Complication-Related Outcomes for Robotic-Assisted versus Open Radical Cystectomy: A Comparative NSQIP Analysis.
February 1, 2024
Tumour tissue-derived small extracellular vesicles reflect molecular subtypes of bladder cancer.
February 1, 2024